Skip to content

Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer

The Gambro Polyflux HD-C4 Small Ease of Use Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00579202
Enrollment
24
Registered
2007-12-21
Start date
2007-10-31
Completion date
2007-11-30
Last updated
2025-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis

Keywords

Dialyzer

Brief summary

The purpose of the study is to study the ease of use of the Polyflux HD-C4 Small dialyzer under conditions of routine clinical use for hemodialysis

Detailed description

Market evaluation protocol. This ease of use study involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy. This study is strictly aimed at obtaining feedback from the nursing and technical staff regarding the use of the Polyflux HD-C4 Small dialyzer. The dialysis nursing staff will complete ease of use assessments following routine dialysis therapy.

Interventions

DEVICEGambro HD-C4 Small Dialyzer

Involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy.

Sponsors

Gambro Renal Products, Inc.
CollaboratorINDUSTRY
Baxter Healthcare Corporation
CollaboratorINDUSTRY
Vantive Health LLC
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* n/a routine dialysis patients

Exclusion criteria

* n/a routine dialysis patients

Design outcomes

Primary

MeasureTime frame
For each dialyzer, the perceived ease of priming.During priming of each dialyzer

Secondary

MeasureTime frame
Visual assessment of residual blood in the dialyzer after rinse-back and if dialyzer clotted during treatment.At the completion of each treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026